Getinge : Watch Innovations with Ed Begley, Jr. episode featuring NAVA, Getinge’s unique approach to ventilation
July 12, 2018 at 06:29 pm IST
Share
A recent episode of Innovations with Ed Begley Jr., an award-winning television series on CNBC, featured NAVA, an innovative approach to ventilation developed by Getinge.
NAVA is controlled directly by the patient's own neural control of breathing and is based on the electrical signal from the patient's diaphragm. The episode explains how NAVA improves patient-ventilator interactions, which can lead to an improved ICU experience for the patient by decreasing the need for sedation, reducing complications and significantly decreasing the amount of time needed on the ventilator.
Innovations with Ed Begley, Jr.highlights cutting-edge advances in medicine, science and technology, including remarkable solutions to issues that consumers face in their day-to-day lives.
Learn more about NAVA.
Attachments
Original document
Permalink
Disclaimer
Getinge AB published this content on 12 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 July 2018 12:58:02 UTC
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows:
- medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.;
- hospital sterilization equipment (29.4%);
- contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications.
Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%).
At the end of 2021, the group had 20 production sites worldwide.
Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).